Latest filing published 02 Jun 2008 for PHARMACOPEIA DRUG DISCOVERY INC, €447.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Eric J. Liebler: trading record in brief
Filings by Eric J. Liebler span 2 companies, the busiest being Pharmacopeia Drug Discovery Inc and Questcor Pharmaceuticals Inc. We count 33 filings; the first trade dates from 15 March 2007 and the latest from 30 May 2008.
No open-market sale appears; the market trades are 18 purchases worth €87k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 15 share grants.
A typical purchase (the median) is worth €1,157.
Most recently, on 2 June 2008, the filings show a share grant worth €447 in Pharmacopeia Drug Discovery Inc. The last purchase on record was published on 7 December 2007, which is 6,912 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Eric J. Liebler
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 161.11 shares@ US$4.31Common StockSEC:0001273013-08-000049:0
- 35,000 shares0Common StockSEC:0001273013-08-000042:0
- 207.28 shares@ US$3.35Common StockSEC:0001273013-08-000035:0
- 334.08 shares@ US$3.65Common StockSEC:0001273013-08-000017:0
- 186.82 shares@ US$3.68Common StockSEC:0001273013-08-000008:0
- 159.11 shares@ US$4.19Common StockSEC:0001382436-08-000006:0
- 286 shares@ US$4.42Common StockSEC:0001273013-07-000080:0Canonical exit: 4 Mar 2008 (T+90)
- 400 shares@ US$4.43Common StockSEC:0001273013-07-000080:1Canonical exit: 4 Mar 2008 (T+90)
- 362 shares@ US$4.44Common StockSEC:0001273013-07-000080:2Canonical exit: 4 Mar 2008 (T+90)
- 4,602 shares@ US$4.45Common StockSEC:0001273013-07-000080:3Canonical exit: 4 Mar 2008 (T+90)
- 3,550 shares@ US$4.46Common StockSEC:0001273013-07-000080:4Canonical exit: 4 Mar 2008 (T+90)
- 400 shares@ US$4.47Common StockSEC:0001273013-07-000080:5Canonical exit: 4 Mar 2008 (T+90)
- 300 shares@ US$4.48Common StockSEC:0001273013-07-000080:6Canonical exit: 4 Mar 2008 (T+90)
- 1,400 shares@ US$4.49Common StockSEC:0001273013-07-000080:7Canonical exit: 4 Mar 2008 (T+90)
- 3,700 shares@ US$4.50Common StockSEC:0001273013-07-000080:8Canonical exit: 4 Mar 2008 (T+90)
- 5,000 shares@ US$4.55Common StockSEC:0001273013-07-000080:9Canonical exit: 5 Mar 2008 (T+90)
- 23,900 shares@ US$0.85Common StockSEC:0001144204-07-013270:0
- 10,600 shares@ US$0.849Common StockSEC:0001144204-07-013270:1
- 1,400 shares@ US$0.83Common StockSEC:0001144204-07-013270:2
- 600 shares@ US$0.82Common StockSEC:0001144204-07-013270:3
- 1,000 shares@ US$0.81Common StockSEC:0001144204-07-013270:4
- 800 shares@ US$0.80Common StockSEC:0001144204-07-013270:5
- 500 shares@ US$0.79Common StockSEC:0001144204-07-013270:6
- 1,200 shares@ US$0.78Common StockSEC:0001144204-07-013270:7
24 of 24 declarations